alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))

Term ID

CHEBI:141194

Synonyms

globoside Fuc-Branched-Forssman (d18:1(4E))
N-acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-(alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4))-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(
N-acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-(alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4))-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyl-sphing-4

Definition

References

PMID:414913

Ontology

ChEBI ( EBI )

Relationships

is a type of: alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide organic molecular entity

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide organic molecular entity Show first 5 Terms
has_functional_parent: alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E)) Show first 5 Terms

Phenotype

Phenotype resulting from alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))

Phenotype where environments contain alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))

Phenotype modified by environments containing alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))

Human Disease Model